Genprex, Inc. (GNPX)
3.48
-0.06
(-1.69%)
USD |
NASDAQ |
Sep 09, 11:41
Genprex Total Assets (Quarterly) : 17.14M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.14M |
| March 31, 2026 | 20.31M |
| December 31, 2025 | 10.16M |
| September 30, 2025 | 3.562M |
| June 30, 2025 | 3.828M |
| March 31, 2025 | 6.010M |
| December 31, 2024 | 4.124M |
| September 30, 2024 | 3.907M |
| June 30, 2024 | 6.605M |
| March 31, 2024 | 12.56M |
| December 31, 2023 | 10.67M |
| September 30, 2023 | 16.64M |
| June 30, 2023 | 15.91M |
| March 31, 2023 | 23.32M |
| December 31, 2022 | 25.08M |
| September 30, 2022 | 29.95M |
| June 30, 2022 | 34.57M |
| March 31, 2022 | 39.41M |
| December 31, 2021 | 42.86M |
| September 30, 2021 | 46.33M |
| Date | Value |
|---|---|
| June 30, 2021 | 48.73M |
| March 31, 2021 | 51.04M |
| December 31, 2020 | 31.37M |
| September 30, 2020 | 23.35M |
| June 30, 2020 | 24.75M |
| March 31, 2020 | 24.64M |
| December 31, 2019 | 3.534M |
| September 30, 2019 | 4.068M |
| June 30, 2019 | 6.264M |
| March 31, 2019 | 7.476M |
| December 31, 2018 | 9.269M |
| September 30, 2018 | 11.05M |
| June 30, 2018 | 12.89M |
| March 31, 2018 | 1.386M |
| December 31, 2017 | 1.260M |
| September 30, 2017 | 1.267M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.910M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.342M |
| Shareholders Equity (Quarterly) | 14.80M |
| Current Ratio | 6.765 |